Indicaton
Cancer Immunotherapy Enhancer
ApyraMed has shown to promote the effective generation of self-renewing anti-tumor cytotoxic T cells and synergize with ICIs in controlling tumor growth, thus resulting in superior survival in experimental models of solid tumors.
